Etomidate as a rectal induction agent. Part II. A clinical study in children

Area of Science:

• Anesthesiology
• Pediatric Medicine
• Pharmacology

Background:

• Establishing safe and effective anesthetic induction methods for pediatric patients is crucial.
• Intravenous or inhalational induction can be challenging in young children, particularly those who are unpremedicated.
• Rectal administration offers an alternative route for drug delivery in pediatric anesthesia.

Purpose of the Study:

• To evaluate the efficacy and safety of rectal etomidate for inducing general anesthesia in children aged 6 months to 5 years.
• To determine the optimal dosage range for rectal etomidate administration.
• To assess the onset of hypnosis, recovery time, and potential side effects.

Main Methods:

• A preliminary study in rats preceded the administration of 1.25% etomidate solution rectally to 40 children.
• Doses ranged from 3.0 mg/kg to 6.5 mg/kg, with hypnosis onset, muscle movements, and cardiovascular/respiratory parameters monitored.
• Recovery from anesthesia and 24-hour postoperative observations were recorded.

Main Results:

• Hypnosis occurred within 4 minutes in all children receiving 6.5 mg/kg of rectal etomidate.
• Cardiovascular and respiratory parameters remained stable throughout the procedure.
• No delay in recovery from subsequent inhalational anesthesia or evidence of rectal mucosal irritation was observed.
• The lowest effective hypnotic dose was 4.5 mg/kg.

Conclusions:

• Rectal administration of 1.25% etomidate is a safe and effective method for inducing general anesthesia in children.
• This route provides a rapid and predictable onset of hypnosis and allows for quick recovery.
• Rectal etomidate is highly suitable for outpatient anesthesia in unpremedicated children who may resist other induction methods.